|

Induction Carboplatin Clinical Trials

1 actively recruiting trial

Also known as: Carboplatin, Etoposide, Pembrolizumab, Sacituzumab Govitecan

Pipeline

Phase 2: 1

Top Sponsors

  • Nir Peled1

Indications

  • NSCLC (Non-small Cell Lung Cancer)1
  • Lung Cancer1
  • Cancer1

Other1 trial

First Line Therapy for Extensive SCLC Patients, Treated with Chemo+Keytruda Followed by Keytuda+Trodelvy
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.